Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 1685 3626 3683 3697
This examiner grants 28% of resolved cases
Neal Sereboff is an examiner in Tech Center 3600 and Art Unit 1685. The examiner has 511 resolved cases, with an allowance rate of 28.2 percent. This rate indicates the frequency of grants during prosecution. The median days to allowance is 1744, which is the period for reaching a grant.
The interview lift of 33.3 percent suggests that interviews are a way to increase the 28.2 percent allowance rate. This 33.3 percent lift is a strategic consideration for practitioners. With 511 resolved cases, the statistics are supported in Art Unit 1685. The 1744 day median pendency is a factor in the prosecution process in Tech Center 3600. Applicants can use the interview lift to navigate the allowance landscape.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18725394 | BADGE AND PATIENT SUPPORT APPARATUS COMMUNICATION SYSTEM | Non-Final OA | Stryker Corporation |
| 18200003 | HEALTH DATABASE UPDATING | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18885353 | AUTOMATIC MEDICATION ORDER GENERATION | Final Rejection | Oracle International Corporation |
| 18352390 | METHOD OF DIFFERENTIATING PATTERNS OF CARE | Non-Final OA | International Business Machines Corporation |
| 18978350 | MEDICAL RECORD DIGEST | Non-Final OA | ZOLL Medical Corporation |
| 19170306 | METHODS AND SYSTEMS USING DEEP-LEARNING FOR IDENTIFYING PULMONARY VEIN ISOLATION NON-RESPONDERS | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18743404 | PERSONALIZED CARE RECOMMENDATION USING GENETICS ANALYSIS | Final Rejection | ELC MANAGEMENT LLC |
| 18757266 | NUTRITION AND DEPRESCRIPTION | Non-Final OA | CVS Pharmacy, Inc. |
| 18242335 | PERSONALIZED RENAL FAILURE CHRONIC CARE SYSTEMS AND METHODS | Final Rejection | BAXTER HEALTHCARE SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy